Ikuma Shioi

Ikuma Shioi

colorectal surgery, Gunma University, Maebashi, Gunma, Japan
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2024 in Cancers
Verified
Journal Article
Open access
PDF file
NMNatsumi Mori
Natsumi Mori
GDGendensuren Dorjkhorloo
Gendensuren Dorjkhorloo
TSTakuya Shiraishi
Takuya Shiraishi
BOBilguun Erkhem Ochir
Bilguun Erkhem Ochir
HOHaruka Okami
Haruka Okami
HSHiroshi Saeki
Hiroshi Saeki
Tertiary lymphoid structures (TLSs) are complex lymphocyte clusters that arise in non-lymphoid tissues due to inflammation or cancer. A mature TLS with proliferating germinal centers is associated with a favorable prognosis in various cancers. However, the effect of TLS maturity on advanced colorectal cancer (CRC) remains unexplored. We analyzed the significance of TLS maturity and tumor Ki-67 expression in surgically resected tumors from 78 patients with pathological T4 CRC. Mature TLS was defined as the organized infiltration of T and B cells with Ki-67-positive proliferating germinal centers. We analyzed the relationship between TLS maturity and intratumoral immune cell infiltration. Mature TLS with germinal center Ki-67 expression was associated with microsatellite instability and improved survival; however, high tumor Ki-67 expression was associated with poor survival in the same cohort. Multivariate analysis identified the absence of mature TLS as an independent predictor of poor post-recurrence overall survival. Intratumoral infiltration of T lymphocytes and macrophages was significantly elevated in tumors with mature TLS compared to those lacking it. High Ki-67 levels and absent mature TLS were identified as poor prognostic factors in advanced CRC. Mature TLS could serve as a promising marker for patients at high-risk of CRC.

Verified
Journal Article
Open access
PDF file
YSYuta Shibasaki
Yuta Shibasaki
Takehiko YokoboriTakehiko Yokobori
Takehiko Yokobori
MSMakoto Sohda
Makoto Sohda
ISIkuma Shioi
Ikuma Shioi
NONaoya Ozawa
Naoya Ozawa
HSHiroshi Saeki
Hiroshi Saeki
The mammalian target of rapamycin (mTOR) is often activated in several cancers. We focused on two mTOR regulatory mechanisms: oxaliplatin-induced mTOR signaling and L-type amino acid transporter 1 (LAT1)-induced mTOR activation. High LAT1 expression in several cancers is associated with mTOR activation and resistance to chemotherapy. However, the significance of LAT1 has not yet been elucidated in colorectal cancer (CRC) patients treated with post-operative adjuvant chemotherapy. Immunohistochemistry was conducted to examine the significance of membrane LAT1 expression in 98 CRC patients who received adjuvant chemotherapy, including oxaliplatin. In vitro analysis was performed using CRC cell lines to determine the effects of LAT1 suppression on proliferation, oxaliplatin sensitivity, and mTOR signaling. LAT1 expression was associated with cancer aggressiveness and poor prognosis in 98 CRC patients treated with adjuvant chemotherapy. We found that positive LAT1 expression correlated with shorter survival in 43 patients treated with the capecitabine-plus-oxaliplatin (CAPOX) regimen. LAT1 suppression in CRC cells inhibited the proliferation potency and oxaliplatin-induced activation of mTOR signaling, and improved oxaliplatin sensitivity. LAT1 evaluation before adjuvant treatment may therefore be a sensitive marker for oxaliplatin-based regimens. Moreover, LAT1 may be a promising target for patients with refractory CRC.

23 May 2025 in Techniques in Coloproctology
Verified
Journal Article
Open access
PDF file
ISIkuma Shioi
Ikuma Shioi
TSTakuya Shiraishi
Takuya Shiraishi
YSYutaro Shimizu
Yutaro Shimizu
KUKosei Uehara
Kosei Uehara
TSTakahiro Seki
Takahiro Seki
HSHiroshi Saeki
Hiroshi Saeki
Background The optimal surgical approach for advanced or recurrent rectal cancer with invasion of adjacent structures remains controversial. This study aimed to clarify the feasibility of laparoscopic two-team transanal beyond total mesorectal excision in patients with advanced and recurrent rectal cancer with invasion. Methods This single-center retrospective study was conducted in a single educational hospital in Japan from January 2014 to March 2024. Patients with advanced or recurrent rectal cancer who underwent laparoscopic or two-team transanal total mesorectal excision with the resection of adjacent structures were included in the analysis. Short-term outcomes were compared between the laparoscopic and transanal approaches. The burden of medical resources was assessed using a new index, Staff Time Consumed (STC = median number of participating staff members × operation time). Results In total, 35 patients were included. More patients underwent preoperative treatment and lateral lymph-node dissection using the transanal approach. However, the operative time (539 and 339 min in the laparoscopic and transanal groups, respectively; p < 0.001) and total blood loss (274 and 70 mL, respectively; p = 0.008) were lower in the transanal group. Additionally, the positive resection margin was lower in the transanal group than in the laparoscopic group (28% and 0%, p = 0.021); STC was comparable between groups. There was no increase in postoperative mortality or morbidity. Patients with surgical difficulties had shorter operative times in the transanal group, and comparable STC. Conclusions Laparoscopic two-team transanal approach offers better short-term outcomes than the conventional approach in highly selected patients.

16 May 2020 in JGH Open
Verified
Journal Article
Open access
PDF file
ISIkuma Shioi
Ikuma Shioi
YYYusuke Yamaoka
Yusuke Yamaoka
ASAkio Shiomi
Akio Shiomi
HKHiroyasu Kagawa
Hiroyasu Kagawa
HHHitoshi Hino
Hitoshi Hino
DADaisuke Aizawa
Daisuke Aizawa
An 85‐year‐old woman was admitted to a hospital with abdominal pain. Five years prior to admission, she had a history of hilar cholangiocarcinoma of pStage IIIC. Contrast‐enhanced computed tomography showed a mass between the rectum and uterus as well as bowel obstruction due to the lesion. Colonoscopy showed severe stenosis at the lower rectum and elevation of the submucosal layer with linear erosion. Rectal cancer was suspected, and pelvic recurrence of hilar cholangiocarcinoma or endometrial carcinoma infiltrating the rectum was considered as differential diagnosis. She underwent robot‐assisted low anterior resection combined with partial resection of the uterus. The immunohistopathological findings of the resected specimen favored a diagnosis of metastasis of cholangiocarcinoma, rather than primary rectal cancer or endometrial carcinoma. There were no signs of recurrence after 10 months of follow‐up. Hilar cholangiocarcinoma is a disease with poor prognosis. Recurrence is frequently experienced even after curative resection. Patients with recurrence are rarely candidates for re‐resection. However, better prognosis is reported for those with complete resection.

1 January 2021 in The Japanese Journal of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
ISIkuma Shioi
Ikuma Shioi
HHHitoshi Hino
Hitoshi Hino
ASAkio Shiomi
Akio Shiomi
YYYusuke Yamamoto
Yusuke Yamamoto
HKHiroyasu Kagawa
Hiroyasu Kagawa
KUKatsuhiko Uesaka
Katsuhiko Uesaka
症例1は73歳の男性で,上行結腸癌cT4b(十二指腸,右腎)N2M1(PUL1)cStage IVに対して結腸右半切除術,右腎摘出術,膵温存十二指腸切除術(pancreas-sparing duodenectomy;以下,PSDと略記)を施行した.症例2は73歳の女性で,上行結腸癌 cT4b(十二指腸,右腎)N2M0 cStage IIIbに対して結腸右半切除術,右腎摘出術,胆囊摘出術,PSDを施行した.いずれの症例も広範な十二指腸浸潤を認めたが,PSDで完全切除可能であった.従来,広範な十二指腸浸潤を来した大腸癌では膵頭十二指腸切除術が併施されてきたが,高い確率で合併症を発症する.一方,PSDは広範な十二指腸浸潤例にも適応可能であり,術後合併症が比較的少なく,かつ機能温存につながる術式であるとされている.同様の症例に対して,PSDは治療選択肢に含めるべき術式であると考えられる.

1 May 2026 in The Japanese Journal of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
ISIkuma Shioi
Ikuma Shioi
TSTakuya Shiraishi
Takuya Shiraishi
YSYuta Shibasaki
Yuta Shibasaki
CKChika Komine
Chika Komine
TOTakuhisa Okada
Takuhisa Okada
HSHiroshi Saeki
Hiroshi Saeki
症例は55歳の女性で,腹部膨満と下痢を主訴に当院を受診した.腹部CTで下腹部に12 cm大の粘液成分を含む巨大腫瘤を認め,子宮,膀胱,小腸および直腸への浸潤が疑われた.ほか主要臓器に明らかな腫瘤影を認めなかった.大腸内視鏡検査で虫垂開口部と直腸に隆起性病変があり,いずれも粘液癌の所見であった.以上から,虫垂癌cT4bN0M0 cStage IICの診断で,回盲部切除および経肛門アプローチ併用低位前方切除術を施行した.腫瘍は膀胱に浸潤していたものの,温存は可能であった.また,腫瘍骨盤側は経肛門アプローチにより腹部操作からの剥離層の受けを作れたため,効率的な腫瘍周囲操作で切除しえた.病理学的所見では剥離断端陰性であった.術後18か月で無再発生存を確認した.直腸浸潤を伴う巨大虫垂癌の切除例はまれである.本症例では経肛門アプローチ併用手術で安全に切除が可能であった.